FNDC3B promotes epithelial-mesenchymal transition in tongue squamous cell carcinoma cells in a hypoxic microenvironment Corrigendum in /10.3892/or.2020.7744 Corrigendum in /10.3892/or.2021.8067

Zhong,Zhaoming; Zhang,Hongxing; Hong,Min; Sun,Chuanzheng; Xu,Yuanyuan; Chen,Xiao; Gao,Change; He,Minjie; Liu,Weiqing; Liang,Jin

doi:10.3892/or.2018.6231

FNDC3B promotes epithelial-mesenchymal transition in tongue squamous cell carcinoma cells in a hypoxic microenvironment

Corrigendum in: /10.3892/or.2020.7744 Corrigendum in: /10.3892/or.2021.8067

Authors:
- Zhaoming Zhong
- Hongxing Zhang
- Min Hong
- Chuanzheng Sun
- Yuanyuan Xu
- Xiao Chen
- Change Gao
- Minjie He
- Weiqing Liu
- Jin Liang
View Affiliations

Affiliations: Department of Medical Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China, Department of Head and Neck Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China, Department of Oncology, The First People's Hospital of Kunming, Kunming, Yunnan 650032, P.R. China
Published online on: January 24, 2018 https://doi.org/10.3892/or.2018.6231
Pages: 1853-1859

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The primary reasons for the treatment failure of patients with oral tongue squamous cell carcinoma (OTSCC) are metastasis and tumor recurrence. Identifying the exact mechanisms underlying metastasis is a key point in improving patient prognosis. It has been reported that a hypoxic microenvironment plays an important role during the metastasis of malignancies. We found that the expression of fibronectin type III domain containing 3B (FNDC3B) is positively correlated with lymph node metastasis and advanced cTNM stage of OTSCC by IHC assay and correlation analysis. Furthermore, we found that knockdown of FNDC3B could suppress the migratory and invasive abilities of OTSCC cells. In addition, treating OTSCC cells with CoCl2 (a hypoxia mimetic agent) upregulated the mRNA and protein expression of FNDC3B via HIF-1α. Moreover, the resultant increase in FNDC3B expression significantly induced epithelial-mesenchymal transition (EMT) in OTSCC cells. The present study elucidated the important role played by FNDC3B in OTSCC metastasis and indicates FNDC3B as a potential target for the treatment of OTSCC metastasis. However, many questions remain to be explored.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	Otsuka Y, Sato H, Oikawa T, Onodera Y, Nam JM, Hashimoto A, Fukunaga K, Hatanaka KC, Hatanaka Y, Matsuno Y, et al: High expression of EPB41L5, an integral component of the Arf6-driven mesenchymal program, correlates with poor prognosis of squamous cell carcinoma of the tongue. Cell Commun Signal. 14:282016. View Article : Google Scholar : PubMed/NCBI
3	Burusapat C, Jarungroongruangchai W and Charoenpitakchai M: Prognostic factors of cervical node status in head and neck squamous cell carcinoma. World J Surg Oncol. 13:512015. View Article : Google Scholar : PubMed/NCBI
4	Haksever M, Inançlı HM, Tunçel U, Kürkçüoğlu SS, Uyar M, Genç O and Irkkan C: The effects of tumor size, degree of differentiation, and depth of invasion on the risk of neck node metastasis in squamous cell carcinoma of the oral cavity. Ear Nose Throat J. 91:130–135. 2012.PubMed/NCBI
5	Feng HJ, Bao YL, Liang ZP, Zhao FP, Xu SE, Xu W, Zhao C and Qin G: Silencing of FANCD2 enhances the radiosensitivity of metastatic cervical lymph node-derived head and neck squamous cell carcinoma HSC-4 cells. Int J Oncol. 50:1241–1250. 2017. View Article : Google Scholar
6	Katoh D, Nishizuka M, Osada S and Imagawa M and Imagawa M: Fad104, a positive regulator of adipocyte differentiation, suppresses invasion and metastasis of melanoma cells by inhibition of STAT3 activity. PLoS One. 10:e01171972015. View Article : Google Scholar : PubMed/NCBI
7	Wang HY, McMahon C, Ali SM, Young LE, Yekezare S, Ross JS and Ball ED: Novel FNDC3B and MECOM fusion and WT1 L378fs* 7 frameshift mutation in an acute myeloid leukaemia patient with cytomorphological and immunophenotypic features reminiscent of acute promyelocytic leukaemia. Br J Haematol. 172:987–990. 2016. View Article : Google Scholar : PubMed/NCBI
8	Nishizuka M, Kishimoto K, Kato A, Ikawa M, Okabe M, Sato R, Niida H, Nakanishi M, Osada S and Imagawa M: Disruption of the novel gene fad104 causes rapid postnatal death and attenuation of cell proliferation, adhesion, spreading and migration. Exp Cell Res. 315:809–819. 2009. View Article : Google Scholar : PubMed/NCBI
9	Kishimoto K, Nishizuka M, Ueda T, Kajita K, Ugawa S, Shimada S, Osada S and Imagawa M: Indispensable role of factor for adipocyte differentiation 104 (fad104) in lung maturation. Exp Cell Res. 317:2110–2123. 2011. View Article : Google Scholar : PubMed/NCBI
10	Urtreger AJWS, Werbajh SE, Verrecchia F, Mauviel A, Puricelli LI, Kornblihtt AR and Bal de Kier Joffé ED: Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential. Oncol Rep. 16:1403–1410. 2006.PubMed/NCBI
11	Lin CH, Lin YW, Chen YC, Liao CC, Jou YS, Hsu MT and Chen CF: FNDC3B promotes cell migration and tumor metastasis in hepatocellular carcinoma. Oncotarget. 7:49498–49508. 2016.PubMed/NCBI
12	Yang Y, Li D, Yang Y and Jiang G: An integrated analysis of the effects of microRNA and mRNA on esophageal squamous cell carcinoma. Mol Med Rep. 12:945–952. 2015. View Article : Google Scholar : PubMed/NCBI
13	Xu H, Hu Y and Qiu W: Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B. Biomed Pharmacother. 87:405–411. 2017. View Article : Google Scholar : PubMed/NCBI
14	Stangeland B, Mughal AA, Grieg Z, Sandberg CJ, Joel M, Nygård S, Meling T, Murrell W, Vik Mo EO and Langmoen IA: Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Oncotarget. 6:26192–26215. 2015. View Article : Google Scholar : PubMed/NCBI
15	Sawey ET, Chanrion M, Cai C, Wu G, Zhang J, Zender L, Zhao A, Busuttil RW, Yee H, Stein L, et al: Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Cancer Cell. 19:347–358. 2011. View Article : Google Scholar : PubMed/NCBI
16	Ibrahim AA, Schmithals C, Kowarz E, Köberle V, Kakoschky B, Pleli T, Kollmar O, Nitsch S, Waidmann O, Finkelmeier F, et al: Hypoxia causes down-regulation of Dicer in hepatocellular carcinoma, which is required for up-regulation of hypoxia inducible factor 1alpha and epithelial-mesenchymal transition. Clin Cancer Res. 23:3896–3905. 2017. View Article : Google Scholar : PubMed/NCBI
17	Ye LY, Chen W, Bai XL, Xu XY, Zhang Q, Xia XF, Sun X, Li GG, Hu QD, Fu QH, et al: Hypoxia-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma induces an immunosuppressive tumor microenvironment to promote metastasis. Cancer Res. 76:818–830. 2016. View Article : Google Scholar : PubMed/NCBI
18	Zhong Z, Hu Z, Jiang Y, Sun R, Chen X, Chu H, Zeng M and Sun C: Interleukin-11 promotes epithelial-mesenchymal transition in anaplastic thyroid carcinoma cells through PI3K/Akt/GSK3β signaling pathway activation. Oncotarget. 7:59652–59663. 2016. View Article : Google Scholar : PubMed/NCBI
19	Wu Y, Wang Y, Lin Y, Liu Y, Wang Y, Jia J, Singh P, Chi YI, Wang C, Dong C, et al: Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation. Nat Commun. 8:142282017.doi: 10.1038/ncomms14228. View Article : Google Scholar : PubMed/NCBI
20	Zhang T, Liang L, Liu X, Wu JN, Chen J, Su K, Zheng Q, Huang H and Liao GQ: TGFβ1-Smad3-Jagged1-Notch1-Slug signaling pathway takes part in tumorigenesis and progress of tongue squamous cell carcinoma. J Oral Pathol Med. 45:486–493. 2016. View Article : Google Scholar : PubMed/NCBI
21	Shi ZM, Wang L, Shen H, Jiang CF, Ge X, Li DM, Wen YY, Sun HR, Pan MH, Li W, et al: Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling. Oncogene. 36:2577–2588. 2017. View Article : Google Scholar : PubMed/NCBI
22	Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th. Springer; New York: 2010
23	Estilo CL, O-charoenrat P, Talbot S, Socci ND, Carlson DL, Ghossein R, Williams T, Yonekawa Y, Ramanathan Y, Boyle JO, et al: Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer. 9:112009. View Article : Google Scholar : PubMed/NCBI
24	Kuriakose MA, Chen WT, He ZM, Sikora AG, Zhang P, Zhang ZY, Qiu WL, Hsu DF, McMunn-Coffran C, Brown SM, et al: Selection and validation of differentially expressed genes in head and neck cancer. Cell Mol Life Sci. 61:1372–1383. 2004. View Article : Google Scholar : PubMed/NCBI
25	Pyeon D, Newton MA, Lambert PF, den Boon JA, Sengupta S, Marsit CJ, Woodworth CD, Connor JP, Haugen TH, Smith EM, et al: Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res. 67:4605–4619. 2007. View Article : Google Scholar : PubMed/NCBI
26	Talbot SG, Estilo C, Maghami E, Sarkaria IS, Pham DK, O-charoenrat P, Socci ND, Ngai I, Carlson D, Ghossein R, et al: Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung. Cancer Res. 65:3063–3071. 2005. View Article : Google Scholar : PubMed/NCBI
27	Ye H, Yu T, Temam S, Ziober BL, Wang J, Schwartz JL, Mao L, Wong DT and Zhou X: Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics. 9:692008. View Article : Google Scholar : PubMed/NCBI
28	Książkiewicz M, Markiewicz A and Zaczek AJ: Epithelial-mesenchymal transition: A hallmark in metastasis formation linking circulating tumor cells and cancer stem cells. Pathobiology. 79:195–208. 2012. View Article : Google Scholar : PubMed/NCBI
29	Nieto MA: Context-specific roles of EMT programmes in cancer cell dissemination. Nat Cell Biol. 19:416–418. 2017. View Article : Google Scholar : PubMed/NCBI
30	Cai C, Rajaram M, Zhou X, Liu Q, Marchica J, Li J and Powers RS: Activation of multiple cancer pathways and tumor maintenance function of the 3q amplified oncogene FNDC3B. Cell Cycle. 11:1773–1781. 2012. View Article : Google Scholar : PubMed/NCBI